Immunosuppression-state-of-the-art: Anything new in the pipeline?

Keyphrases

• Immunosuppression 100%
• Clinical Trials 66%
• Immunosuppressive Agents 66%
• Cardiac Allograft Vasculopathy 66%
• High Dose 33%
• Cyclosporine 33%
• Long-term Survival 33%
• Malignancy 33%
• Long-term Complications 33%
• Tacrolimus 33%
• Widespread Adoption 33%
• Nephrotoxicity 33%
• Mycophenolate Mofetil 33%
• Cardiac Transplantation 33%
• Anticancer Agents 33%
• MTOR Inhibitor 33%
• Rituximab 33%
• New Agents 33%
• Proliferation Signal Inhibitors 33%
• Acute Decompensated Heart Failure 33%
• Immunosuppressive Regimens 33%
• Post-transplant Survival 33%
• Rejection Rate 33%

Medicine and Dentistry

• Immunosuppressive Treatment 100%
• Immunosuppressive Drug 75%
• Clinical Trial 50%
• Side Effect 50%
• Cardiac Allograft Vasculopathy 50%
• Infection 25%
• Drug Megadose 25%
• Transplantation 25%
• Cancer 25%
• Long Term Survival 25%
• Tacrolimus 25%
• Cyclosporine 25%
• Congestive Heart Failure 25%
• Mammalian Target of Rapamycin Inhibitor 25%
• Rituximab 25%
• Heart Transplantation 25%
• Nephrotoxicity 25%
• Azathioprine 25%
• Mycophenolate Mofetil 25%
• Anticancer Drug 25%